• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL2200893 莫非赛定利托那韦片 morphothiadine mesylate;ritonavir Tablet Chemical Drugs(1) New Drug Application 2022-11-12 Sunshine Lake Pharma Co Ltd view
JYHB1400866 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2014-07-18 AbbVie Ltd, Abbvie Ltd Certificate Issued 2015-01-27 view
JTH2200240 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Disposable Import Drug Application 2022-12-21 view
JYHB1601599 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2016-12-06 AbbVie Ltd, Abbvie Ltd Certificate Issued 2017-07-18 view
JYHB1001167 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2010-12-31 Abbott Laboratories Limited Abbott Laboratories Ltd Certificate Issued 2011-08-29 view
CYHS2200484 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(4) Generic Drug 2022-03-24 Shanghai DESANO Biopharmaceutical Co Ltd view
JYHB1500737 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2015-06-02 AbbVie Ltd, Abbvie Ltd Certificate Issued 2016-07-18 view
JYHS2300030 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs(5.2) Import Drug Application 2023-02-22 view
JYHB2000638 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-05-27 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Filed 2020-06-09 view
JYHZ1700275 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2017-08-21 AbbVie Ltd. Abbvie Ltd Certificate Issued 2018-03-19 view
JYHB1000056 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2010-02-03 Abbott Laboratories Limited Abbott Laboratories Ltd Certificate Issued 2010-06-24 view
JYHB1900177 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-02-12 AbbVie Deutschland GmbH & Co. KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2019-09-23 view
JYHB1901349 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2019-11-13 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-01-20 view
JYHB1601600 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2016-12-06 AbbVie Ltd. Abbvie Ltd Certificate Issued 2017-05-04 view
JYHB2001606 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-08-28 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Certificate Issued 2020-11-24 view
JYHB1001168 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2010-12-31 Abbott Laboratories Limited Abbott Laboratories Ltd Certificate Issued 2011-08-29 view
JYHB1401281 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2014-09-17 AbbVie Ltd, Abbvie Ltd Certificate Issued 2015-01-27 view
JYHB2000637 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2020-05-27 AbbVie Deutschland GmbH & Co.KG Abbvie Deutschland Gmbh & Co KG Filed 2020-06-09 view
JYHB0901041 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs Supplementary Application 2009-12-04 Abbott Laboratories Limited Abbott Laboratories Ltd Certificate Issued 2010-05-18 view
JYHZ2200202 洛匹那韦利托那韦片 lopinavir;ritonavir Tablet Chemical Drugs License Renew 2022-07-18 view